National Health Investors, Inc. (NHI) 股票分析

公司概述

National Health Investors, Inc. operates as a self-managed real estate investment trust with a specialized focus on sale-leaseback transactions, joint ventures, and mortgage or mezzanine financing for senior housing and medical facilities that serve both need-driven and discretionary markets. The company functions within the Real Estate sector, specifically classified under the REIT - Healthcare Facilities industry, which denotes its primary asset class consists of healthcare infrastructure rather than corporate office space or residential properties. This entity employs a workforce of 32 individuals and maintains a market capitalization of $4.17B while generating annual revenue of $379.29M based on trailing twelve-month data. These valuation and revenue figures indicate that NHI is a mid-to-large capitalized entity within the specialized healthcare REIT sub-sector, possessing significant assets relative to its lean employee base. The substantial market cap suggests that the market values the company's portfolio of independent living facilities at a premium that reflects long-term lease stability and the high barrier to entry in the healthcare real estate domain.

财务健康

The company reported trailing twelve-month revenue of $379.29M, net income of $141.98M, and EBITDA of $276.77M, revealing a distinct gap between top-line generation and bottom-line profitability. The difference between the $379.29M revenue and the $141.98M net income highlights a rigorous cost structure where operating expenses, including property management and debt servicing, consume a significant portion of gross receipts before reaching net income. Free cash flow stands at $195.47M, which provides the company with substantial financial flexibility to service its existing obligations or pursue capital allocation strategies without relying solely on external financing. Regarding profitability metrics, the gross margin is 81.0%, the operating margin is 61.3%, and the profit margin is 37.5%, indicating that the company retains a high percentage of revenue after direct costs and before interest and taxes, but faces notable pressures from interest expenses and other operating costs to reach the final profit level. On the balance sheet, the company holds $113.38M in cash against $1.52B in total debt, resulting in a debt-to-equity ratio of 97.57%, which signifies a highly leveraged financial position where debt obligations nearly equal the equity base. The current ratio of 0.54 indicates that current assets are less than current liabilities, suggesting potential challenges in meeting short-term obligations without refinancing or asset liquidation. Return on equity is 9.6% and return on assets is 4.5%, metrics that reveal the efficiency of management in generating returns relative to shareholders' equity and the total asset base, respectively, though the low ROA relative to ROE underscores the impact of high leverage on overall asset productivity.

估值评估

National Health Investors, Inc. trades with a trailing P/E ratio of 28.51 and a forward P/E of 23.66, implying that the market expects earnings to recover and grow in the future to justify the lower forward multiple compared to the historical trailing multiple. The price-to-book ratio is 2.55, indicating that the market values the company at a significant premium over its net tangible book value, likely due to the quality of its leasehold assets and stable cash flows. Alternative valuation metrics show a price-to-sales ratio of 11.00 and an EV/EBITDA of 20.19, suggesting that the stock is priced relative to sales at levels high for a REIT, while the EV/EBITDA reflects a multiple that incorporates both market capitalization and net debt to assess enterprise value. The 52-week high is $91.38 and the 52-week low is $66.41, meaning the current trading price sits within this historical range but requires a specific calculation to determine its exact percentage distance from the high or low based on the current market price. The beta value is 0.66, which indicates that the stock price is less volatile than the broader market, suggesting a defensive characteristic often associated with essential healthcare real estate assets during periods of market fluctuation.

Growth & Income

Year-over-year revenue growth stands at -2.6% while earnings growth is -43.0%, demonstrating that earnings are shrinking at a significantly faster rate than revenue, which implies a potential compression in profit margins or a one-time impact on earnings that is not reflected in the top line. As a dividend payer, the company offers a dividend yield of 4.2% but maintains a payout ratio of 120.5%, indicating that the dividend exceeds the current earnings generated by the company. This payout ratio above 100% suggests that the company is paying dividends from cash reserves or capital appreciation rather than organic earnings, raising questions regarding the sustainability of the dividend if earnings do not improve in the near term. Overall, the growth and income profile presents a complex picture of a mature asset-heavy business with high current yield that is currently experiencing earnings contraction and a leveraged balance sheet that constrains organic growth potential.